Kidney Infection Market Report by Manufacturers, Types, Applications and Regions, Global Status and Forecast to 2023
Research Reports
Jan 05, 2021
Market Analysis
Kidney infection mostly occurs as a result of infection in the bladder that travels to the kidney. If remains untreated, the kidney infection may lead to the kidney damage. Therefore, there is a need for early diagnosis and treatment of kidney diseases. CT scan, ultrasound, and X-ray are the effective diagnostics methods for a kidney infection. It can be treated with medications such as antibiotics, and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
The global kidney infection market is projected to grow at a 5.2% CAGR between 2017-2023, as per the recent Market Research Future (MRFR) report. Kidney infection, also known as pyelonephritis, often occurs from infections in the urinary tract, which spreads to the kidneys. These infections can be chronic or sudden, and if not treated at the right time, can be painful and life-threatening. Nausea and vomiting, fever, back pain, pain while urinating, smelly or cloudy urine, and blood in the urine are some of the common symptoms of kidney infection.
Numerous factors are adding to the global kidney infection market growth. These factors, according to the recent Market Research Future report, comprise the introduction of new services and products by key players in emerging economies and developing countries, rising geriatric population, good investments in new technology development, increased application, and favorable reimbursement policies. Additional factors adding to the market growth include a growing need for better treatment methods, increasing investments in R&D by pharmaceutical and biotechnology industries, and the rising prevalence of kidney infections.
On the contrary, high treatment costs may deter the global kidney infection market growth during the forecast period.
Key Players
Leading players profiled in the global kidney infection market report include Teva Pharmaceutical Industries Ltd. (Japan), Sanofi (France), Pfizer (U.S.), Kissei Pharmaceutical Co. Ltd. (Japan), Keryx Biopharmaceuticals, Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), GlaxoSmithKline plc. (U.K), F. Hoffmann-La Roche Ltd (Switzerland), AstraZeneca (U.K), Amgen Inc. (U.S.), Allergan plc. (U.K), and AbbVie, Inc. (U.S.). Key players have incorporated several strategies to stay ahead in the competition, such as strategic alliances, partnerships, mergers & acquisitions, and product launches.
To Know More Download Sample PDF of Report:https://www.marketresearchfuture.com/sample_request/5192
Regional Analysis
By region, the global kidney infection market report covers the latest trends and growth opportunities across the Americas, the Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA). Of these, the Americas will lead the market during the forecast period for high health care spending, increasing support from the government for R&D activities, rising patient population for kidney infection, and the availability of advanced medical devices both for diagnosis as well as treatment of kidney infection including dialysis machine, and rising patient population for kidney infection. Moreover, the concentration of key companies and increased research and development activities are also adding to the global kidney infection market growth in the region.
The global kidney infection market in Europe is predicted to hold the second-largest share in the market during the forecast period for huge availability of funds for R&D activities, increasing focus on new drug development, and increasing support from the government for research and development. Moreover, the increasing number of specialty services provided by different healthcare providers in the region is also adding market growth. France as well as Germany are the leading contributors in the region owing to increasing focus on hospital infrastructure and rising investment in the healthcare sector.
The global kidney infection market in the APAC region will grow at the fastest pace during the forecast period for high healthcare expenditure and the presence of rapidly expanding healthcare technology. The increasing patient population in India and the growing demand for quality healthcare devices are also adding to the market growth.
The global kidney infection market in the MEA will have a small share in the market during the forecast period for the unavailability of medical devices that are technologically advanced, limited medical facilities, and less availability of funds.
Get Covid-19 Impact Analysis on “kidney Infection Market”:https://www.marketresearchfuture.com/enquiry/5192
Market Segmentation
The Market Research Future report provides an all-inclusive segmental analysis of the global kidney infection market based on end user, treatment, and diagnosis.
By diagnosis, the global kidney infection market is segmented into imaging test and dipstick urine test. The imaging test is again segmented into voiding cystourethrogram, CT scan, ultrasound, and others.
By treatment, the global kidney infection market is segmented into kidney transplants, dialysis, medication, and others. The medication segment is again segmented into non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics.
By end user, the global kidney infection market is segmented into research institutes, nephrology center, hospitals and clinics, and others.
Access Full Report Summary of Report:https://www.marketresearchfuture.com/reports/kidney-infection-market-5192
Tags:
, Reportedtimes, Research Newswire, English